Inhibitory effect of dopaminergic stimulation on GH release in acromegaly.
D000172:Acromegaly / Q000097:blood*; D000328:Adult; D001058:Apomorphine / Q000494:pharmacology; D001120:Arginine / Q000494:pharmacology; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005947:Glucose / Q000494:pharmacology; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007328:Insulin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010919:Placebos; D013997:Time Factors
D007328:Insulin; D010919:Placebos; D004295:Dihydroxyphenylalanine; D013006:Growth Hormone; D001120:Arginine; D002262:Carboxy-Lyases; D005947:Glucose; D001058:Apomorphine